A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer

A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer

This study aims to provide preliminary data on the feasibility and outcomes of a 12 week exercise program on the quality of life of men with hormone refractory prostate cancer receiving docetaxel-based chemotherapy.

Inclusion Criteria:

• diagnosis of prostate cancer
• receiving docetaxel-based chemotherapy at the CCI
• age 18 years or over
• approval of oncologist
• informed written consent

Exclusion Criteria:

• life expectancy less than 6 months
• Karnofsky performance score less than 70
• contraindications for exercise (e.g. uncontrolled cardiac, respiratory, hypertensive or psychiatric disorder)
• unable to understand, read, write and speak English
• unable or unwilling to attend supervised exercise sessions 3 times weekly
• unable or unwilling to complete outcome assessments